April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Ocular Hypothermic Conditioning Prevents Retinal Alterations Induced By Type 2 Diabetes Mellitus
Author Affiliations & Notes
  • Pablo Sande
    Human Biochemistry/Sch of Med, University of Buenos Aires, Buenos Aires, Argentina
  • Ezequiel Salido
    Human Biochemistry/Sch of Med, University of Buenos Aires, Buenos Aires, Argentina
  • Melina P Bordone
    Human Biochemistry/Sch of Med, University of Buenos Aires, Buenos Aires, Argentina
  • Maria F Gonzales Fleitas
    Human Biochemistry/Sch of Med, University of Buenos Aires, Buenos Aires, Argentina
  • Monica Chianelli
    Human Biochemistry/Sch of Med, University of Buenos Aires, Buenos Aires, Argentina
  • Maria I Keller Sarmiento
    Human Biochemistry/Sch of Med, University of Buenos Aires, Buenos Aires, Argentina
  • Damian Dorfman
    Human Biochemistry/Sch of Med, University of Buenos Aires, Buenos Aires, Argentina
  • Ruth Estela Rosenstein
    Human Biochemistry/Sch of Med, University of Buenos Aires, Buenos Aires, Argentina
  • Footnotes
    Commercial Relationships Pablo Sande, None; Ezequiel Salido, None; Melina Bordone, None; Maria Gonzales Fleitas, None; Monica Chianelli, None; Maria Keller Sarmiento, None; Damian Dorfman, None; Ruth Rosenstein, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4438. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pablo Sande, Ezequiel Salido, Melina P Bordone, Maria F Gonzales Fleitas, Monica Chianelli, Maria I Keller Sarmiento, Damian Dorfman, Ruth Estela Rosenstein, ; Ocular Hypothermic Conditioning Prevents Retinal Alterations Induced By Type 2 Diabetes Mellitus. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4438.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Hypothermic conditioning protects the retina against acute ischemic injury. We have developed an experimental model of early type 2 diabetes mellitus (T2DM) in adult rats, by combining diet-induced insulin resistance and a slight β-cell secretory impairment, which mimics some features of human T2DM at its initial stages, and provokes significant retinal alterations. The aim of the present work was to analyze the effect of ocular hypothermic conditioning on the retinal changes induced by a moderate metabolic derangement.

Methods: Adult male Wistar rats received a control diet or 30% sucrose in the drinking water ad libitum. Three weeks after this treatment, animals were injected with vehicle or streptozotocin (STZ, 25 mg/kg). Starting 3 weeks after STZ injection, retroocular temperature was weekly reduced to 32 C for 20 min in one eye, while the contralateral eye was submitted to a sham procedure. At 12 weeks of treatment, fasting and postprandial glycemia, and glucose and insulin tolerance tests were analyzed. Retinal function (scotopic electroretinograms (ERG)), retinal lipid peroxidation (thiobarbituric acid reactive substance levels), NOS activity (using 3H-arginine), TNFα (enzyme-linked immunosorbent assay), retinal morphology (optical microscopy), vascular endothelial growth factor (VEGF), and Müller cell glial fibrillary acidic protein (GFAP) levels (immunohistochemistry) were evaluated.

Results: Animals which received a sucrose-enriched diet and STZ showed significant differences in metabolic tests, as compared with control groups. Weekly ocular hypothermia pulses which did not affect glucose metabolism in control or diabetic rats, prevented the decrease in the scotopic ERG a- and b-wave, and oscillatory potential amplitude, and the increase in retinal lipid peroxidation, NOS activity, TNFα, VEGF, and Müller cell GFAP levels.

Conclusions: These results indicate that ocular hypothermic conditioning can make the retina more tolerant against diabetic damage.

Keywords: 499 diabetic retinopathy • 510 electroretinography: non-clinical • 615 neuroprotection  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×